North America is anticipated to be a major contributor to the growth of the CRISPR in agriculture market. North America is one of the strongest economies across the globe, comprising of around 23.3% of the world economy as per International Monetary Fund in 2017.The economic strength and advanced biotechnological research in agriculture in North America provide a solid platform for the growth of the CRISPR in the agriculture market. Biotechnological research in agriculture is being supported by various government initiatives in the US and Canada. Therefore, increasing government initiatives in the region are encouraging the market growth.
The private sector investment in plant breeding, research, and varietal development of seeds have been growing in the US and Canada. This is due to the high investment by private companies in plant breeding, research, and variety development. Furthermore, several seed companies are investing in growth strategies including mergers and acquisitions, collaboration, and strategic partnership which is anticipated to boost the market for plant breeding which in turn fuels the demand for CRISPR in agriculture. The most recent instances of such growth strategies include the merger of Dow AgroSciences and DuPont which is done to have a synergy benefit of 1 million was done in September 2017, and the acquisition of Monsanto from the US by Bayer from Germany was done in September 2019.
Key players of North America's CRISPR in the agriculture market areBenson Hill Biosystems, Recominatics, cibus ltd., Intellia Therapeutics, Inc., GeneCopoeia Inc., and Calyxt, Inc. among others. These are the major players that are contributing significantly towards the growth of North America's market. Further, strategies adopted by these players such as acquisitions, mergers, investment in R&D activities and product launch are also estimated to have a positive impact on the growth of the CRISPR in the agriculture market. For instance, in October 2017, DuPont Pioneer (the agricultural division of E. I. du Pont de Nemours and Company) entered a non-exclusive global licensing agreement with the Broad Institute of MIT and Harvard for CRISPR-Cas9 gene-editing technology in agriculture. The Broad Institute is engaged in the development of CRISPR-Cas technology and holds multiple issued US patents related to CRISPR-Cas technology.
Research Methodology
The market study of the North American CRISPR in Agriculture market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.
Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. North American CRISPR in Agriculture Market Research and Analysis by End-users
2. North American CRISPR in Agriculture Market Research and Analysis byTarget Type
The Report Covers
The private sector investment in plant breeding, research, and varietal development of seeds have been growing in the US and Canada. This is due to the high investment by private companies in plant breeding, research, and variety development. Furthermore, several seed companies are investing in growth strategies including mergers and acquisitions, collaboration, and strategic partnership which is anticipated to boost the market for plant breeding which in turn fuels the demand for CRISPR in agriculture. The most recent instances of such growth strategies include the merger of Dow AgroSciences and DuPont which is done to have a synergy benefit of 1 million was done in September 2017, and the acquisition of Monsanto from the US by Bayer from Germany was done in September 2019.
Key players of North America's CRISPR in the agriculture market areBenson Hill Biosystems, Recominatics, cibus ltd., Intellia Therapeutics, Inc., GeneCopoeia Inc., and Calyxt, Inc. among others. These are the major players that are contributing significantly towards the growth of North America's market. Further, strategies adopted by these players such as acquisitions, mergers, investment in R&D activities and product launch are also estimated to have a positive impact on the growth of the CRISPR in the agriculture market. For instance, in October 2017, DuPont Pioneer (the agricultural division of E. I. du Pont de Nemours and Company) entered a non-exclusive global licensing agreement with the Broad Institute of MIT and Harvard for CRISPR-Cas9 gene-editing technology in agriculture. The Broad Institute is engaged in the development of CRISPR-Cas technology and holds multiple issued US patents related to CRISPR-Cas technology.
Research Methodology
The market study of the North American CRISPR in Agriculture market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.
Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.
Secondary Sources Include
- Financial reports of companies involved in the market.
- Whitepapers, research-papers, and news blogs.
- Company websites and their product catalog.
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. North American CRISPR in Agriculture Market Research and Analysis by End-users
2. North American CRISPR in Agriculture Market Research and Analysis byTarget Type
The Report Covers
- Comprehensive research methodology of the North American CRISPR in Agriculture market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the North American CRISPR in Agriculture market.
- Insights about market determinants which are stimulating the North American CRISPR in Agriculture market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Table of Contents
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Regional Analysis
7. Company Profiles
Companies Mentioned
A selection of companies mentioned in this report includes:
- Arcadia Biosciences
- Bayer AG
- BASF SE
- Benson Hill Biosystems, Inc.
- Caribou Biosciences, Inc.
- Calyxt, Inc.
- Cibus Ltd.
- DowDupont Inc.
- GeneCopoeia, Inc.
- Horizon Discovery Group, PLC
- Inari Agriculture
